Skip to content
Home/Companies/TMT/Braingaze
Braingaze

Braingaze

TMT·Spain·Active·2yr hold
Entry
2024
Hold
2yr
Status
Active

Who owns Braingaze?

Braingaze is currently owned by Ryse Asset Management through RYSE Special Opportunities Fund (2024 vintage), since 2024.

Hand-verified · updated 2026-04-21

Ryse Asset Management
Investor
Ryse Asset Management
RYSE Special Opportunities Fund · 2024 · VC

Key facts

HQUK
SectorTMT
Websitewww.braingaze.com

More from RYSE Special Opportunities Fund

Other portfolio companies in the same fund.

Ten63 Therapeutics
Ten63 Therapeutics
Active
BiotechUnited States· 2026
Curio Digital Therapeutics
Curio Digital Therapeutics
Active
HealthTechUnited States· 2024
Oto
Oto
Active
HealthTechUnited Kingdom· 2022
Knok
Knok
Active
HealthTechPortugal· 2020
Log My Care
Log My Care
Active
HealthTechUnited Kingdom· 2020

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

52North Health
52North Health
Active
Future Planet CapitalUK
Akrivia Health
Akrivia Health
Active
Future Planet CapitalUK
Paladin
Paladin
Active
Ring CapitalFrance
Access Infinity
Active
CBPE CapitalUK· 2026
Auryx
Active
VentoUnited Kingdom· 2026
Axomove
Axomove
Active
INCO VENTURESFrance· 2026
Track Braingaze

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Braingaze.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue